Thyroid hormones and fear learning but not anxiety are affected in adult apoE transgenic mice exposed postnatally to decabromodiphenyl ether (BDE-209)

Physiology and Behavior

Volumn 133, Issue , 2014, Pages 81-91

  Reverte, Ingrid ^a   Pujol, Andreu ^a   Domingo, José L ^a   Colomina, Maria Teresa ^a  

^a UNIVERSITAT ROVIRA I VIRGILI   (Spain)

Author keywords

Anxiety; Apolipoprotein E; Fear conditioning; Learning; PBDEs; Thyroid hormone

Indexed keywords

APOLIPOPROTEIN E2; APOLIPOPROTEIN E3; APOLIPOPROTEIN E4; BROMINE; DIPHENYL ETHER DERIVATIVE; THYROID HORMONE; APOLIPOPROTEIN E; DECABROMOBIPHENYL ETHER;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANXIETY; ARTICLE; BODY WEIGHT; COGNITIVE DEFECT; CONTROLLED STUDY; ENDOCRINE SYSTEM; FEAR; FEMALE; FREEZING; GENOTYPE; HUMAN; LEARNING; LOCOMOTION; MALE; MOUSE; NERVE DEGENERATION; NONHUMAN; PERINATAL PERIOD; PRENATAL EXPOSURE; PRIORITY JOURNAL; PROTEIN POLYMORPHISM; SPATIAL MEMORY; TRANSGENIC MOUSE; AGE; ANALYSIS OF VARIANCE; ANIMAL; BLOOD; C57BL MOUSE; CONDITIONING; DOSE RESPONSE; DRUG EFFECTS; ETIOLOGY; EXPLORATORY BEHAVIOR; GENETICS; MAZE TEST; MOTOR ACTIVITY; NEWBORN; TOXICITY;

AGE FACTORS; ANALYSIS OF VARIANCE; ANIMALS; ANIMALS, NEWBORN; ANXIETY; APOLIPOPROTEINS E; CONDITIONING (PSYCHOLOGY); DOSE-RESPONSE RELATIONSHIP, DRUG; EXPLORATORY BEHAVIOR; FEAR; FEMALE; HALOGENATED DIPHENYL ETHERS; HUMANS; LEARNING; MALE; MAZE LEARNING; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MOTOR ACTIVITY; THYROID HORMONES;

EID: 84901589676     PISSN: 00319384     EISSN: 1873507X     Source Type: Journal    
DOI: 10.1016/j.physbeh.2014.05.013     Document Type: Article

References (65)

1. Costa L.G., Giordano G. Developmental neurotoxicity of polybrominated diphenyl ether (PBDE) flame retardants. Neurotoxicology 2007, 28:1047-1067.
2. EFSA Scientific Opinion on Polybrominated Diphenyl Ethers (PBDEs) in Food 2011, 9:1-274.
3. Costa L.G., de Laat R., Tagliaferri S., Pellacani C. A mechanistic view of polybrominated diphenyl ether (PBDE) developmental neurotoxicity. Toxicol Lett 2014, [in press]. 10.1016/j.toxlet.2013.11.011.
4. Costa L.G., Giordano G. Is decabromodiphenyl ether (BDE-209) a developmental neurotoxicant?. Neurotoxicology 2011, 32:9-24.
5. Hardy M.L., Banasik M., Stedeford T. Toxicology and human health assessment of decabromodiphenyl ether. Crit Rev Toxicol 2009, 39:1-44.
6. Gascon M., Vrijheid M., Martínez D., Forns J., Grimalt J.O., Torrent M., et al. Effects of pre and postnatal exposure to low levels of polybromodiphenyl ethers on neurodevelopment and thyroid hormone levels at 4years of age. Environ Int 2011, 37:605-611.
7. Herbstman J.B., Sjödin A., Kurzon M., Lederman S.A., Jones R.S., Rauh V., et al. Prenatal exposure to PBDEs and neurodevelopment. Environ Health Perspect 2010, 118:712-719.
8. Hoffman K., Adgent M., Goldman B.D., Sjödin A., Daniels J.L. Lactational exposure to polybrominated diphenyl ethers and its relation to social and emotional development among toddlers. Environ Health Perspect 2012, 120:1438-1442.
9. Johansson N., Viberg H., Fredriksson A., Eriksson P. Neonatal exposure to deca-brominated diphenyl ether (PBDE 209) causes dose-response changes in spontaneous behaviour and cholinergic susceptibility in adult mice. Neurotoxicology 2008, 29:911-919.
10. Viberg H., Fredriksson A., Eriksson P. Changes in spontaneous behaviour and altered response to nicotine in the adult rat, after neonatal exposure to the brominated flame retardant, decabrominated diphenyl ether (PBDE 209). Neurotoxicology 2007, 28:136-142.
11. Viberg H., Fredriksson A., Jakobsson E., Orn U., Eriksson P. Neurobehavioral derangements in adult mice receiving decabrominated diphenyl ether (PBDE 209) during a defined period of neonatal brain development. Toxicol Sci 2003, 76:112-120.
12. Rice D.C., Reeve E.A., Herlihy A., Zoeller R.T., Thompson W.D., Markowski V.P. Developmental delays and locomotor activity in the C57BL6/J mouse following neonatal exposure to the fully-brominated PBDE, decabromodiphenyl ether. Neurotoxicol Teratol 2007, 29:511-520.
13. Rice D.C., Thompson W.D., Reeve E.A., Onos K.D., Assadollahzadeh M., Markowski V.P. Behavioral changes in aging but not young mice after neonatal exposure to the polybrominated flame retardant decaBDE. Environ Health Perspect 2009, 117:1903-1911.
14. Reverte I., Klein A.B., Domingo J.L., Colomina M.T. Long term effects of murine postnatal exposure to decabromodiphenyl ether (BDE-209) on learning and memory are dependent upon APOE polymorphism and age. Neurotoxicol Teratol 2013, 40:17-27.
15. Miodovnik A. Environmental neurotoxicants and developing brain. Mt Sinai J Med 2011, 78:58-77.
16. Branchi I., Capone F., Alleva E., Costa L.G. Polybrominated diphenyl ethers: neurobehavioral effects following developmental exposure. Neurotoxicology 2003, 24:449-462.
17. Darnerud P.O., Aune M., Larsson L., Hallgren S. Plasma PBDE and thyroxine levels in rats exposed to Bromkal or BDE-47. Chemosphere 2007, 67:S386-S392.
18. Driscoll L.L., Gibson A.M., Hieb A. Chronic postnatal DE-71 exposure: effects on learning, attention and thyroxine levels. Neurotoxicol Teratol 2009, 31:76-84.
19. Ellis-Hutchings R.G., Cherr G.N., Hanna L.A., Keen C.L. Polybrominated diphenyl ether (PBDE)-induced alterations in vitamin A and thyroid hormone concentrations in the rat during lactation and early postnatal development. Toxicol Appl Pharmacol 2006, 215:135-145.
20. Kuriyama S.N., Wanner A., Fidalgo-neto A.A., Talsness C.E., Koerner W., Chahoud I. Developmental exposure to low-dose PBDE-99: tissue distribution and thyroid hormone levels. Toxicology 2007, 242:80-90.
21. Richardson V.M., Staskal D.F., Ross D.G., Diliberto J.J., DeVito M.J., Birnbaum L.S. Possible mechanisms of thyroid hormone disruption in mice by BDE 47, a major polybrominated diphenyl ether congener. Toxicol Appl Pharmacol 2008, 226:244-250.
22. Stoker T.E., Laws S.C., Crofton K.M., Hedge J.M., Ferrell J.M., Cooper R.L. Assessment of DE-71, a commercial polybrominated diphenyl ether (PBDE) mixture, in the EDSP male and female pubertal protocols. Toxicol Sci 2004, 78:144-155.
23. Zhou T., Taylor M.M., DeVito M.J., Crofton K.M. Developmental exposure to brominated diphenyl ethers results in thyroid hormone disruption. Toxicol Sci 2002, 66:105-116.
24. Huang F., Wen S., Li J., Zhong Y., Zhao Y., Wu Y. The human body burden of polybrominated diphenyl ethers and their relationships with thyroid hormones in the general population in Northern China. Sci Total Environ 2014, 466-467:609-615.
25. Abdelouahab N., Langlois M.-F., Lavoie L., Corbin F., Pasquier J.-C., Takser L. Maternal and cord-blood thyroid hormone levels and exposure to polybrominated diphenyl ethers and polychlorinated biphenyls during early pregnancy. Am J Epidemiol 2013, 178:701-713.
26. Eskenazi B., Chevrier J., Rauch S.A., Kogut K., Harley K.G., Johnson C., et al. In utero and childhood polybrominated diphenyl ether (PBDE) exposures and neurodevelopment in the CHAMACOS study. Environ Health Perspect 2013, 121:257-262.
27. Bernal J. Thyroid hormone receptors in brain development and function. Nat Clin Pract Endocrinol Metab 2007, 3:249-259.
28. Buras A., Battle L., Landers E., Nguyen T., Vasudevan N. Thyroid hormones regulate anxiety in the male mouse. Horm Behav 2013, 65:88-96.
29. Daubié S., Bisson J.-F., Lalonde R., Schroeder H., Rychen G. Neurobehavioral and physiological effects of low doses of polybrominated diphenyl ether (PBDE)-99 in male adult rats. Toxicol Lett 2011, 204:57-63.
30. Jain R.B. Effect of smoking and caffeine consumption on polybrominated diphenyl ethers (PBDE) and polybrominated biphenyls (PBB). J Toxicol Environ Health A 2013, 76:515-532.
31. La Merrill M., Emond C., Kim M.J., Antignac J.-P., Le Bizec B., Birnbaum L.S., et al. Toxicological function of adipose tissue: focus on persistent organic. Environ Health Perspect 2013, 162:162-169.
32. De Chaves E.P., Narayanaswami V. Apolipoprotein E and cholesterol in aging and disease in the brain. Future Lipidol 2008, 3:505-530.
33. Raber J. AR, apoE, and cognitive function. Horm Behav 2008, 53:706-715.
34. Negash S., Petersen L.E., Geda Y.E., Knopman D.S., Boeve B.F., Smith G.E., et al. Effects of ApoE genotype and mild cognitive impairment on implicit learning. Neurobiol Aging 2007, 28:885-893.
35. Poirier J. Apolipoprotein E, in the brain and its role in Alzheimer's disease. J Psychiatry Neurosci 1996, 21:128-134.
36. Kalueff A.V. Neurobiology of memory and anxiety: from genes to behavior. Neural Plast 2007, 78171.
37. Sullivan P.M., Mezdour H., Aratani Y., Knouff C., Najib J., Reddick R.L., et al. Targeted replacement of the mouse apolipoprotein E gene with the common human APOE3 allele enhances diet-induced hypercholesterolemia and atherosclerosis. J Biol Chem 1997, 272:17972-17980.
38. Eriksson P., Jakobsson E., Fredriksson A. Brominated flame retardants: a novel class of developmental neurotoxicants in our environment?. Environ Health Perspect 2001, 109:903-908.
39. Xing Y., Qin W., Li F., Jia X.F., Jia J. Apolipoprotein E ε4 status modifies the effects of sex hormones on neuropsychiatric symptoms of Alzheimer's disease. Dement Geriatr Cogn Disord 2012, 33(1):35-42.
40. Pfankuch T., Rizk A., Olsen R., Poage C., Raber J. Role of circulating androgen levels in effects of apoE4 on cognitive function. Brain Res 2005, 1053:88-96.
41. Reverte I., Klein A.B., Ratner C., Domingo J.L., Colomina M.T. Behavioral phenotype and BDNF differences related to apoE isoforms and sex in young transgenic mice. Exp Neurol 2012, 237:116-125.
42. Keppel G. Design and Analysis: A Researcher's Handbook 2004.
43. Pendse A.A., Arbones-Mainar J.M., Johnson L.A., Atenburg M., Maeda N. ApoE knock-out and knock-in mice: atherosclerosis, metabolic syndrome, and beyond. J Lipid Res 2009, 50:178-182.
44. Grootendorst J., Bour A., Vogel E., Kelche C., Sullivan P.M., Dodart J.-C., et al. Human apoE targeted replacement mouse lines: h-apoE4 and h-apoE3 mice differ on spatial memory performance and avoidance behavior. Behav Brain Res 2005, 159:1-14.
45. Eriksson P., Viberg H., Jakobsson E., Orn U., Fredriksson A. A brominated flame retardant, 2,2',4,4',5-pentabromodiphenyl ether: uptake, retention, and induction of neurobehavioral alterations in mice during a critical phase of neonatal brain development. Toxicol Sci 2002, 67:98-103.
46. Viberg H., Fredriksson A., Eriksson P. Neonatal exposure to the brominated flame retardant 2,2',4,4',5-pentabromodiphenyl ether causes altered susceptibility in the cholinergic transmitter system in the adult mouse. Toxicol Sci 2002, 67:104-107.
47. Viberg H., Fredriksson A., Eriksson P. Neonatal exposure to polybrominated diphenyl ether (PBDE 153) disrupts spontaneous behaviour, impairs learning and memory, and decreases hippocampal cholinergic receptors in adult mice. Toxicol Appl Pharmacol 2003, 192:95-106.
48. Branchi I., Alleva E., Costa L.G. Effects of perinatal exposure to a polybrominated diphenyl ether (PBDE 99) on mouse neurobehavioural development. Neurotoxicology 2002, 23:375-384.
49. Viberg H., Fredriksson A., Eriksson P. Neonatal exposure to the brominated flame-retardant, 2,2',4,4',5-pentabromodiphenyl ether, decreases cholinergic nicotinic receptors in hippocampus and affects spontaneous behaviour in the adult mouse. Environ Toxicol Pharmacol 2004, 17:61-65.
50. Raber J. Role of apolipoprotein E in anxiety. Neural Plast 2007, 2007:91236.
51. Bourin M., Petit-Demoulière B., Dhonnchadha B.N., Hascöet M. Animal models of anxiety in mice. Fundam Clin Pharmacol 2007, 21:567-574.
52. Robertson J., Curley J., Kaye J., Quinn J., Pfankuch T., Raber J. ApoE isoforms and measures of anxiety in probable AD patients and apoE-/- mice. Neurobiol Aging 2005, 26:637-643.
53. Olsen R.H.J., Agam M., Davis M.J., Raber J. ApoE isoform-dependent deficits in extinction of contextual fear conditioning. Genes Brain Behav 2012, 11:806-812.
54. Segev Y., Michaelson D.M., Rosenblum K. ApoE ε4 is associated with eIF2α phosphorylation and impaired learning in young mice. Neurobiol Aging 2013, 34:863-872.
55. Taylor M., Hedge J., Gilbert M., DeVito M., Crofton K. Perinatal exposure to a polybrominated diphenyl ether mixture (DE-71): disruption of thyroid homeostasis and neurobehavioral development. Abstr B 2003 SOT Meet 2003, 124.
56. Fanselow M.S., Dong H.-W. Are the dorsal and ventral hippocampus functionally distinct structures?. Neuron 2010, 65:7.
57. Onishi B.K.A., Xavier G.F. Contextual, but not auditory, fear conditioning is disrupted by neurotoxic selective lesion of the basal nucleus of amygdala in rats. Neurobiol Learn Mem 2010, 93:165-174.
58. Johansen J.P., Cain C.K., Ostroff L.E., LeDoux J.E. Molecular mechanisms of fear learning and memory. Cell 2011, 147:509-524.
59. Kim T.H., Lee Y.J., Lee E., Kim M.S., Kwack S.J., Kim K.B., et al. Effects of gestational exposure to decabromodiphenyl ether on reproductive parameters, thyroid hormone levels, and neuronal development in Sprague-Dawley rats offspring. J Toxicol Environ Health A 2009, 72:1296-1303.
60. Lee E., Kim T.H., Choi J.S., Nabanata P., Kim N.Y., Ahn M.Y., et al. Evaluation of liver and thyroid toxicity in Sprague-Dawley rats after exposure to polybrominated diphenyl ether BDE-209. J Toxicol Sci 2010, 35:535-545.
61. Van der Ven L.T.M., van de Kuil T., Leonards P.E.G., Slob W., Cantón R.F., Germer S., et al. A 28-day oral dose toxicity study in Wistar rats enhanced to detect endocrine effects of decabromodiphenyl ether (decaBDE). Toxicol Lett 2008, 179:6-14.
62. Benvenga S. A thyroid hormone binding motif is evolutionarily conserved in apolipoproteins. Thyroid 1997, 7:605-611.
63. Gilbert M.E. Impact of low-level thyroid hormone disruption induced by propylthiouracil on brain development and function. Toxicol Sci 2011, 124:432-445.
64. Sui L., Wang F., Liu F., Wang J., Li B.M. Dorsal hippocampal administration of triiodothyronine enhances long-term memory for trace cued and delay contextual fear conditioning in rats. J Neuroendocrinol 2006, 18:811-819.
65. Montero-Pedrazuela A., Fernández-Lamo I., Alieva M., Pereda-Pérez I., Venero C., Guadaño-Ferraz A. Adult-onset hypothyroidism enhances fear memory and upregulates mineralocorticoid and glucocorticoid receptors in the amygdala. PLoS One 2011, 6:e26582.